Phase III randomized clinical trial comparing the effects of autologous bone marrow derived MNC and CD133 cells transplantation in ami patients during CABG
Nasseri, M.H, Aghdami, N, Ahmadi, H, Moshkani Farahani, M, Madani, H, Kazemi-Saleh, D, Hossein-neghad, H, Hosseini, S, Hekmat, S, Ahmadi, Z, Dehghani, M, Saadat, A, Mardpour, S, Hosseini, E.S, Esmaeelzadeh, M, Sadeghi, M, Bahoosh, G, Bassi, A, Amin, A, Fazeli, R, Sharafi, Y, Arab, L, Movahed, M, Ramazanzadeh, N, Kohkan, A, Hezavee, A, Namiri, M, Kashfi, F, Akhlaghi, A, Baharvand, H, Vosough, A, Gourabi, H, Shahverdi, A
Published in Cytotherapy (Oxford, England) (01.04.2013)
Published in Cytotherapy (Oxford, England) (01.04.2013)
Get full text
Journal Article